Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-14-002392
Filing Date
2014-05-15
Accepted
2014-05-15 14:49:57
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051514.htm 10-Q 1204915
2 EXHIBIT 31.1 exh_311.htm EX-31.1 11030
3 EXHIBIT 31.2 exh_312.htm EX-31.2 11119
4 EXHIBIT 32.1 exh_321.htm EX-32.1 8124
  Complete submission text file 0001171843-14-002392.txt   5658919

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT args-20140331.xml EX-101.INS 825951
6 XBRL TAXONOMY EXTENSION SCHEMA args-20140331.xsd EX-101.SCH 41520
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE args-20140331_cal.xml EX-101.CAL 34386
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE args-20140331_def.xml EX-101.DEF 215424
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE args-20140331_lab.xml EX-101.LAB 318151
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE args-20140331_pre.xml EX-101.PRE 217234
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Filer) CIK: 0001105533 (see all company filings)

EIN.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35443 | Film No.: 14846332
SIC: 2834 Pharmaceutical Preparations